Sort   by:  
 Page size 
ProteomicsProteomes of chromatin fractions derived from SU-DHL-5 cells
SU-DHL-5 cells display limited expression of the SUMO isopeptidase SENP6. In this experiment, the chromatin associated fraction of SU-DHL-5 cells was analysed by mass spectrometry. SU-DHL-5 cells were either stably transfected with an empty vector or with a SENP6 expression construct. Changes in pro...
ORGANISM(S): Homo sapiens (Human) 
2022-02-17 | PXD027355 | Pride
Su-dhl-5 cells (b-cell lymphoma) 
Genomicshuman SU-DHL-5 and TMD-8 B-lymphome cell line subclones
Genetic heterogeneity though common in tumors has been rarely documented in cell lines. To examine how often B-lymphoma cell lines are comprised of subclones, we performed immunoglobulin (Ig) heavy chain hypermutation analysis. Revealing that subclones are not rare in B-cell lymphoma cell lines, 6/4...
ORGANISM(S): Homo sapiens 
2016-09-30 | E-MTAB-4956 | biostudies-arrayexpress
TranscriptomicsAffymetrix SNP array data for 4 MYC-negative B-cell lymphoma cases and 2 B-cell lymphoma cell lines (SU-DHL-5 and HT)
Affymetrix SNP arrays were performed according to the manufacturer's directions on DNA extracted from blood samples and cell lines Copy number analysis of Affymetrix SNP 6.0 arrays was performed for 4 MYC-negative B-cell lymphoma and 2 B-cell lymphoma cell lines
ORGANISM(S): Homo sapiens 
2014-01-10 | E-GEOD-47507 | biostudies-arrayexpress
Transcriptomicshuman HG-3 B-lymphome cell line subclones
Genetic heterogeneity though common in tumors has been rarely documented in cell lines. To examine how often B-lymphoma cell lines are comprised of subclones, we performed immunoglobulin (Ig) heavy chain hypermutation analysis. Revealing that subclones are not rare in B-cell lymphoma cell lines, 6/4...
ORGANISM(S): Homo sapiens 
2016-09-30 | E-MTAB-4955 | biostudies-arrayexpress
Genomicshuman SU-DHL-5 and TMD-8 B-lymphome cell line subclones
human SU-DHL-5 and TMD-8 B-lymphome cell line subclones
PRJEB14876 | ENA
ProteomicsData in support of Proteomic study of diffuse large B-cell lymphoma identifies proteins associated to single drug components of R-CHOP
Diffuse large B-cell lymphoma (DLBCL) is a molecularly and pathogenically heterogenous disease with varying clinical outcomes which is reflected in the substantial group of patients developing relapse/refractory disease (rrDLBCL) after standard treatment with the combinatory regimen R-CHOP. The mole...
ORGANISM(S): Homo sapiens (Human) 
2025-12-08 | PXD064483 | Pride
Rrdlbcl R-cho Dlbcl 
TranscriptomicsEffect of ALK kinase inhibitor, ceritinib, on the gene expression profile of SUDHL-1 cell line
Tyrosine kinase receptor anaplastic lymphoma kinase (ALK) is physiologically expressed during embryogenesis. However, chromosomal rearrangements, especially translocations, cause expression of pathogenic ALK fusion proteins that drive tumor formation and maintenance. For instance, the translocation ...
ORGANISM(S): Homo sapiens 
2026-01-01 | E-MTAB-15866 | biostudies-arrayexpress
TranscriptomicssiRNA smart pool silencing of master regulators of Follicular Lymphoma transformation to DLBCL
Follicular lymphoma (FL) is the most common indolent subtype of non-Hodgkin’s lymphoma, with relatively long overall survival rate ranging from 6 to 10 years from time of diagnosis. However, 20-60% of FL patients undergo transformation to aggressive diffuse large B cell lymphoma (DLBCL), with a re...
ORGANISM(S): Homo sapiens 
2015-11-11 | E-GEOD-66714 | biostudies-arrayexpress
UnknownEpigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy.
Not available
S-EPMC7574348 | biostudies-literature
UnknownEctopic expression of homeobox gene NKX2-1 in diffuse large B-cell lymphoma is mediated by aberrant chromatin modifications.
Not available
S-EPMC3639244 | biostudies-literature
Sort   by:  
 Page size